A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Lavery MJ, Nawimana S, Parslew R, Stewart L, et al. Clin Exp Dermatol 2021;46:1325-1327.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lavery MJ, Nawimana S, Parslew R, Stewart L, et al. A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Clin Exp Dermatol 2021;46:1325-1327.
PMID: 33914926